Measles IgG Avidity Assay
- PMID: 38743375
- DOI: 10.1007/978-1-0716-3870-5_18
Measles IgG Avidity Assay
Abstract
Measles IgG avidity assays determine the overall strength of molecular binding between measles-specific IgG antibodies and measles virus antigens. Avidity results can distinguish recent from distant measles virus infections. Individuals who are immunologically naïve to measles virus develop low-avidity antibodies upon measles virus infection or first-time vaccination. Within 4-6 months, antibodies mature to high avidity. Measles avidity assays are most useful in the context of measles elimination. In such settings, avidity and epidemiological and clinical information are used to classify measles breakthrough infections for control and surveillance purposes and to assist in case confirmation when other laboratory results are inconclusive or nonexistent. We present a highly accurate end-titer measles avidity assay that delivers results based on IgG quality (avidity) that are independent of IgG concentration.
Keywords: Antibodies; Antigen; Avidity; Elimination; Immunoassay; Immunoglobulin G; Measles; Serology; Serum; Vaccine failure classification.
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Kuby J (1997) Immunology. W. H. Freeman, New York
-
- El Mubarak HS, Ibrahim SA, Vos HW et al (2004) Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J Med Virol 72:290–298. https://doi.org/10.1002/jmv.10553
-
- Mercader S, Garcia P, Bellini WJ (2012) Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings. Clin Vaccine Immunol 19:1810–1817. https://doi.org/10.1128/CVI.00406-12
MeSH terms
LinkOut - more resources
Full Text Sources
Medical